# Eli Lilly Stock Surges on Weight-Loss Drug Demand

> Eli Lilly stock jumps 6% to $1.3 trillion as weight-loss drug sales beat expectations.
- Title: Eli Lilly Stock Surges on Weight-Loss Drug Demand | Shortify
- Summary: Eli Lilly stock jumps 6% to $1.3 trillion as weight-loss drug sales beat expectations. Eli Lilly's stock hit a record $1.3 trillion valuation after…
- Keywords: eli lilly, mounjaro, zepbound, weight-loss drugs, stock surge, market cap, obesity-drug market, foundayo, wegovy, news, entertainment, Eli
- Source: New York Post — https://nypost.com/2026/10/29/business/demand-for-weight-loss-drugs-fuels-eli-lilly-stock-surge-market-cap-hits-1-2-trillion
- Published: 2026-10-29T16:59:58+00:00
- Read time: 1 min
- Topics: eli lilly, mounjaro, zepbound, weight-loss drugs, stock surge, market cap, obesity-drug market, foundayo, wegovy, news, entertainment
## Stock Hits Record High
Eli Lilly stock jumped 6% to a record $1.3 trillion valuation after raising full-year earnings forecasts.
## Weight-Loss Drug Sales Beat Expectations
Sales of Mounjaro and Zepbound exceeded forecasts by over 5%, solidifying Eli Lilly's lead in the obesity-drug market.
## Medicare Patients Using Injections
Over half a million Medicare patients use the injections at a reduced $50-a-month price tag.
## Profit Outlook Adjusted Down
The company reduced forecasted profit shares by 50 cents after recent acquisitions of AtaiBeckley and Curevo.
## Key takeaway

Eli Lilly's stock hit a record $1.3 trillion valuation after weight-loss drug sales exceeded forecasts by over 5%.